
News
Read the latest news from Sciad and our clients
Client News
Client News
New survey suggests that 9 out of 10 patients on warfarin would find self-monitoring an easy and quick way to monitor their health
2nd May 2017
Client News
Client News
Latest work from top UK cancer researchers could hold potential for ‘game-changing’ treatments for rare bile duct cancer
25th April 2017
Client News
ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Programme for RSV Antiviral RV521 in Healthy Volunteers
24th April 2017
Client News
Synpromics raises £5.2m of new investment
19th April 2017
Client News
The RSA Group appoints Shawn O’Connor as Partner in New Jersey
19th April 2017
Client News
Client News
BioCity makes FT 1000 list of Europe’s fastest growing companies
10th April 2017
Client News
ATUM Launches Cell-Line Development Service
Expansion is Supported by four Broad Patents for Company’s Leap-In Transposase® Technology
10th April 2017
Client News
Client News
Nuclear architecture emerges at the awakening of the genome
6th April 2017
Client News
Matt Vossler joins The RSA Group as Partner in North America
3rd April 2017
Client News
Oppilotech Secures Funding From CARB-X to Fight Drug Resistant Infections
30th March 2017
Client News
ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Programme for RSV Antiviral RV521 in Healthy Volunteers
24th April 2017
Client News
Synpromics raises £5.2m of new investment
19th April 2017
Client News
The RSA Group appoints Shawn O’Connor as Partner in New Jersey
19th April 2017
Client News
Client News
BioCity makes FT 1000 list of Europe’s fastest growing companies
10th April 2017
Client News
ATUM Launches Cell-Line Development Service
Expansion is Supported by four Broad Patents for Company’s Leap-In Transposase® Technology
10th April 2017
Client News
Client News
Nuclear architecture emerges at the awakening of the genome
6th April 2017
Client News
Matt Vossler joins The RSA Group as Partner in North America
3rd April 2017
Client News
Oppilotech Secures Funding From CARB-X to Fight Drug Resistant Infections
30th March 2017
Loading
Got an innovation you need bringing to life?
We’d love to hear from you! Head to our contact page to start a conversation.
